Cambridge Cognition Holdings Plc (AIM:COG)
London · Delayed Price · Currency is GBP · Price in GBX 28.00
+0.50 (1.82%)
Dec 31, 2025, 2:28 PM GMT+1
AIM:COG Market Cap
AIM:COG has a market cap or net worth of 11.72 million as of December 31, 2025. Its market cap has decreased by -6.15% in one year.
Market Cap
11.72M
Enterprise Value
12.78M
Revenue
9.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.00
Market Cap Chart
Since April 18, 2013, AIM:COG's market cap has decreased from 13.12M to 11.72M, a decrease of -10.63%. That is a compound annual growth rate of -0.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 11.72M | -24.92% |
| Dec 31, 2024 | 15.61M | -2.50% |
| Dec 29, 2023 | 16.01M | -54.81% |
| Dec 30, 2022 | 35.44M | -9.78% |
| Dec 31, 2021 | 39.28M | 88.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.40B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |